Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjunctive Aripiprazole for Weight and Metabolic Outcomes in Females
NCT06590298Phase 4Not yet recruiting
- Sponsor
- Universiti Putra Malaysia
- Start
- Sep 2024
- Primary completion
- Mar 2025
- Modality
- Small Molecules
01
Overview
Phase 4, randomised trial of aripiprazole in metabolic syndrome (2 arms), sponsored by Universiti Putra Malaysia. Primary endpoint: Mean change in body weight at 6 months. Planned start Sep 2024; status: not yet recruiting.
02
Drugs
aripiprazole
03
Conditions
metabolic syndrome
Beyond the preview
Go deeper on NCT06590298.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06590298.